Vuno Inc (338220) - Product Pipeline Analysis, 2026 Update
Description
Summary
Vuno Inc (Vuno) is a company that focuses on developing artificial intelligence solutions for the medical industry. The company's main activities include creating AI-based diagnostic tools that analyze medical imaging, pathology, bio-signals, and speech recognition data. Its products include VUNO Med-Chest X-ray, VUNO Med-BoneAge, VUNO Med-DeepBrain, and VUNO Med-Fundus AI, among others. Vuno's products are designed to assist healthcare professionals in diagnosing and managing various medical conditions. Its solutions are utilized by medical practitioners in hospitals and clinics to improve diagnostic accuracy and efficiency. The company collaborates with healthcare institutions and integrates its solutions with existing medical systems. VUNO is headquartered in Seoul, South Korea.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
Vuno Inc (Vuno) is a company that focuses on developing artificial intelligence solutions for the medical industry. The company's main activities include creating AI-based diagnostic tools that analyze medical imaging, pathology, bio-signals, and speech recognition data. Its products include VUNO Med-Chest X-ray, VUNO Med-BoneAge, VUNO Med-DeepBrain, and VUNO Med-Fundus AI, among others. Vuno's products are designed to assist healthcare professionals in diagnosing and managing various medical conditions. Its solutions are utilized by medical practitioners in hospitals and clinics to improve diagnostic accuracy and efficiency. The company collaborates with healthcare institutions and integrates its solutions with existing medical systems. VUNO is headquartered in Seoul, South Korea.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Vuno Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
35 Pages
- Vuno Inc Company Overview
- Vuno Inc Company Snapshot
- Vuno Inc Pipeline Products and Ongoing Clinical Trials Overview
- Vuno Inc – Pipeline Analysis Overview
- Vuno Inc - Key Facts
- Vuno Inc - Major Products and Services
- Vuno Inc Pipeline Products by Development Stage
- Vuno Inc Pipeline Products Overview
- AI-Based Disease Detection Software
- AI-Based Disease Detection Software Product Overview
- Artificial Intelligence Device - Arrhythmia
- Artificial Intelligence Device - Arrhythmia Product Overview
- Second Gen VUNO Med - Chest X-ray
- Second Gen VUNO Med - Chest X-ray Product Overview
- Vuno iREAD
- Vuno iREAD Product Overview
- VUNO Med - DeepECG
- VUNO Med - DeepECG Product Overview
- VUNO Med-DeepCARS
- VUNO Med-DeepCARS Product Overview
- VUNO Med-PATH GC AI
- VUNO Med-PATH GC AI Product Overview
- VUNO Med-Path Pros AI
- VUNO Med-Path Pros AI Product Overview
- Vuno Inc - Key Competitors
- Vuno Inc - Key Employees
- Vuno Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- Vuno Inc, Recent Developments
- Feb 04, 2026: Viewno’s 2025 Sales Are Expected to Reach KRW 34.8 Billion, a 35% Year-Over-Year Increase and Its Best-Ever Performance
- Jan 27, 2026: Vuno’s DeepCARS confirms 46% reduction in in-hospital cardiac arrest
- Nov 27, 2025: Vuno to Host 1st Global AI Patient-Safety Summit in Seoul This February
- Nov 12, 2025: VUNO Reports Q3 Profit Driven by DeepCARS Growth
- Oct 28, 2025: VUNO Partners with European Firms to Advance DeepCARS Market Entry in Europe
- Sep 11, 2025: VUNO sells bone age AI business to Maihub to focus on core strategy
- Aug 27, 2025: VUNO to Present 4 AI-Powered ECG Studies at ESC Congress 2025
- May 26, 2025: Vuno Showcases DeepCARS at AACN NTI 2025, Highlighting AI-Driven Cardiac Arrest Risk Prediction
- May 13, 2025: VUNO's cardiac arrest risk monitoring system gains EU and UK certification
- May 12, 2025: Vuno’s AI-Powered Cardiac Arrest Risk Management System Earns CE MDR and UKCA Certifications
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Vuno Inc Pipeline Products and Ongoing Clinical Trials Overview
- Vuno Inc Pipeline Products by Equipment Type
- Vuno Inc Pipeline Products by Indication
- Vuno Inc, Key Facts
- Vuno Inc, Major Products and Services
- Vuno Inc Number of Pipeline Products by Development Stage
- Vuno Inc Pipeline Products Summary by Development Stage
- AI-Based Disease Detection Software - Product Status
- AI-Based Disease Detection Software - Product Description
- Artificial Intelligence Device - Arrhythmia - Product Status
- Artificial Intelligence Device - Arrhythmia - Product Description
- Second Gen VUNO Med - Chest X-ray - Product Status
- Second Gen VUNO Med - Chest X-ray - Product Description
- Vuno iREAD - Product Status
- Vuno iREAD - Product Description
- VUNO Med - DeepECG - Product Status
- VUNO Med - DeepECG - Product Description
- VUNO Med-DeepCARS - Product Status
- VUNO Med-DeepCARS - Product Description
- VUNO Med-PATH GC AI - Product Status
- VUNO Med-PATH GC AI - Product Description
- VUNO Med-Path Pros AI - Product Status
- VUNO Med-Path Pros AI - Product Description
- Vuno Inc, Key Employees
- Glossary
- List of Figures
- Vuno Inc Pipeline Products by Equipment Type
- Vuno Inc Pipeline Products by Development Stage
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
